long intergenic non-protein coding RNA 1971Genealiases: []
Q-omics provides the consensus-scored LINC01971 profile across patient tissues and cancer cell-line models. LINC01971 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC01971 is differentially expressed in 11, with the highest sampling consensus in COAD. Additionally, LINC01971 RNA expression shows 15,341 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UVM, COAD, and THYM as cancer lineages where LINC01971 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01971 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01971 survival associations across molecular data types. LINC01971 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01971 RNA expression–survival associations across cancer types. High LINC01971 expression shows unfavorable associations in UVM, KIRC, KIRP and BLCA, but favorable associations in LUAD and UCS. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC01971 RNA expression.
This table summarizes LINC01971 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01971. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01971 shows higher tumor expression in COAD, UCEC, LUAD, BLCA, LUSC and HNSC. The COAD box plot shows higher LINC01971 RNA expression in tumor versus normal tissue (log2 FC = +0.156, t-test p < 0.001).
This table shows molecular features associated with LINC01971 in patient tissues and cancer cell lines. In patient samples, LINC01971 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
